News and Trends 24 Mar 2020 Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II …nivolumab alone, with no serious adverse events attributable to the vaccine. The therapeutic vaccine candidate is designed to make the immune system target 5T4, a protein present on the surface… March 24, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2022 Cancer Research UK Deploys €700M to Foster Oncology Startups …Horizons (CRH). “But the charity reacted quickly, cutting costs where necessary and adapting fundraising events.” As a result of high donor generosity and the charity’s preparedness, CRUK expects to lose… April 27, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Sponsored 28 Oct 2019 How can Proteomics Boost the Discovery of Novel Drugs and Biomarkers? …compartment-specific localization within cells, splicing events, different post-translational modifications, and interactions with other proteins. All of this adds to the complexity of the proteome, but also provides valuable information for… October 28, 2019 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 16 Feb 2021 Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze …of charity shops and the postponement of major fundraising events such as the London marathon. In the case of BioInvent, the partners renegotiated a deal struck in 2015. According to… February 16, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2017 Cutting Through the BS in Biopharma: How To Spot Hype …makes the news less interesting, then so be it. Moreover, everyone on the panel nodded vigorously in agreement that scientific events are absolutely newsworthy: we shouldn’t feel bad about getting… July 5, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 May 2023 5 cancers that immunotherapy can cure …their partner proteins on tumor cells. This prevents an ‘off’ signal from being sent to the T cells, which allows them to recognize and destroy the cancer cells. Immunotherapy for… May 9, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2025 The gender gap in clinical trials: Why women are still underrepresented …How to keep this transition toward inclusion going According to Seay, to successfully operate the transition, it is important to address each obstacle that prevents women from being adequately represented… March 11, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jul 2021 The Top European Biotech Funding Rounds in June While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing focused more on gene therapy and drug discovery. Last month saw some momentous events for… July 8, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Sep 2021 Slow-Release Jab for Child Growth Hormone Deficiency Gets FDA Nod …of the hormone inside a protective molecule that inactivates it and prevents it from being broken down by the body. When the drug is injected into the bloodstream, the hormone… September 1, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2018 Gene Therapy for Retinitis Pigmentosa Tested in Humans for the First Time …outcome measure is safety: the absence of adverse events,” CEO Christine Placet told me. “Then we will try to capture some signal of improvement of the visual function.” In particular,… July 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 31 May 2022 Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments …is a substantial body of preclinical data available which demonstrates that inhibition of the mPTP in the brain prevents neuronal cell death, reduces neuroinflammation and extends survival in animals. With… May 31, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2023 Janssen reports positive topline phase 2 HDFN results …without a need for an intrauterine transfusion (IUT) throughout the entire pregnancy. Adverse events were monitored up to approximately 24 weeks post-delivery for parents and up to approximately 96 weeks… February 10, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email